PLAU Gene: Urokinase-Type Plasminogen Activator

A key serine protease involved in fibrinolysis, cell migration, and tissue remodeling, with implications in cancer and inflammatory diseases.

Gene Information Card

Symbol PLAU
Full Name Plasminogen Activator, Urokinase
Gene Type Protein coding
Chromosomal Location 10q22.2
NCBI Gene ID 5328 ncbi.nlm.nih.gov/gene/5328
Ensembl ID ENSG00000122861
UniProt ID P00749
OMIM ID 191840
HGNC ID 9052
Aliases uPA, URK, ATF, U-PA

Description

The PLAU gene encodes urokinase-type plasminogen activator (uPA), a serine protease that converts plasminogen to plasmin. uPA is involved in extracellular matrix degradation, cell migration, and tissue remodeling. It plays critical roles in fibrinolysis, wound healing, and cancer invasion/metastasis. Dysregulation of PLAU expression is associated with various malignancies and inflammatory conditions.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cancer (multiple types) Overexpression of uPA enhances plasmin-mediated degradation of extracellular matrix, promoting tumor invasion and metastasis. NCBI Gene, COSMIC
Alzheimer's disease uPA-mediated plasmin generation may contribute to amyloid-beta clearance dysregulation. NCBI Gene, OMIM
Inflammatory bowel disease Elevated uPA activity correlates with tissue destruction and inflammation. NCBI Gene, ClinVar

Expression Profile

Tissue Expression
Tissue nTPM level
Lung 12.5 Medium
Kidney 9.8 Medium
Breast 6.3 Low
Liver 4.1 Low
Placenta 15.2 High
Cell Line Expression
Cell Line nTPM Notes
A549 (lung carcinoma) 18.7 High expression
MCF7 (breast cancer) 7.2 Moderate expression
HEK293 (embryonic kidney) 5.4 Low expression
HepG2 (hepatocellular carcinoma) 3.1 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.422C>T (p.Thr141Met) Missense <0.01% Reduced catalytic activity
c.1A>G (p.Met1Val) Start loss <0.01% Loss of protein expression
c.788G>A (p.Arg263Gln) Missense <0.01% Altered substrate binding
Mutation functional classification

Loss of Function (LOF)

Mutations such as start loss (p.Met1Val) lead to complete loss of uPA protein, impairing fibrinolysis and cell migration.

Gain of Function (GOF)

No well-characterized gain-of-function mutations reported in PLAU.

Dominant Negative (DN)

No dominant-negative mutations described for PLAU.

Gene Ontology (GO)

• serine-type endopeptidase activity • plasminogen activation
• extracellular matrix disassembly • cell migration
• proteolysis

Pathways

Plasminogen activating cascade
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling
Focal adhesion
ECM-receptor interaction

Protein Summary

The uPA protein (UniProt P00749) is a 431-amino-acid serine protease secreted as a single-chain zymogen (pro-uPA). Proteolytic cleavage generates an active two-chain form. The A-chain contains an epidermal growth factor-like domain and a kringle domain; the B-chain carries the catalytic triad (His204, Asp255, Ser356). uPA binds to its receptor (uPAR) on cell surfaces, localizing plasminogen activation to the pericellular environment.

Related Products

Product name Cat.No. Species Gene ID
PLAUR Knockout HEK293 Cell Line EDJ-KQ3817 Human 5329 Details Get a Quote
PLAU Knockout HEK293 Cell Line EDJ-KQ17699 Human 5328 Details Get a Quote
PLAU Knockout A-549 Cell Line EDJ-KQ18997 Human 5328 Details Get a Quote
PLAU Knockout HCT 116 Cell Line EDJ-KQ18998 Human 5328 Details Get a Quote
PLAU Knockout HeLa Cell Line EDJ-KQ18999 Human 5328 Details Get a Quote
PLAUR Knockout A-549 Cell Line EDJ-KQ25947 Human 5329 Details Get a Quote
PLAUR Knockout HeLa Cell Line EDJ-KQ25948 Human 5329 Details Get a Quote
PLAUR Knockout HCT 116 Cell Line EDJ-KQ24591 Human 5329 Details Get a Quote
PLAUR Knockout HAP1 Cell Line EDC07992 Human 5329 Details Get a Quote
Displaying Records 1 To 9 Of 9 Records
Contact Us
*
*
*
*
How did you hear about us: